Evidence map›Paper›PMID 37449085›Full record

ArticleGynecologic oncology reports2023

Durable remission in a patient with

Alexander J Neil, Michael G Muto, David L Kolin, Panagiotis A Konstantinopoulos

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alexander J NeilDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Michael G MutoDivision of Gynecologic Oncology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA.
David L KolinDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Panagiotis A KonstantinopoulosDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
Brigham and Women's Hospital · USDana-Farber Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with advanced stage or recurrent mucinous ovarian carcinoma exhibit poor response to standard platinum- and taxane-based chemotherapy and poor prognosis. We report a 29-year-old patient with recurrent

Indexed as

Carboplatin/Paclitaxel chemotherapyERBB2Expansile growthHER2Mucinous ovarian cancerTrastuzumab

Identifiers

PMID37449085
PMCPMC10336730
OpenAlexW4383501103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.